A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
Condition: Kidney Cancer, Prostate Cancer, Bladder Cancer
Purpose: Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient’s treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT02186925
Sponsor: Meir Medical Center
Primary Outcome Measures:
- Measure: Progression Free Survival
- Time Frame: 5 years
- Safety Issue:
Secondary Outcome Measures:
- Measure: Patient overall survival
- Time Frame: 5 years
- Safety Issue:
Estimated Enrollment: 1000
Study Start Date: August 2014
Notice: Undefined property: stdClass::$phase in /home/urotoday/public_html/administrator/components/com_clinicaltrials/ClinicalTrials/Trial.php on line 192
Phase: Notice: Undefined property: stdClass::$phase in /home/urotoday/public_html/administrator/components/com_clinicaltrials/ClinicalTrials/Trial.php on line 192
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.
Exclusion Criteria:
- Patients under the age of 18
Contact:
- Daniel Kejzman, MD
- daniel.kejzman@clalit.org.il
- 00972-9747-1606
Location:
- Meir Medical Center
- Kvar Saba 4428164 Israel
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}